Thermosensitive hydrogels to deliver reactive species generated by cold atmospheric plasma: a case study with methylcellulose

Hydrogels have been recently proposed as suitable materials to generate reactive oxygen and nitrogen species (RONS) upon gas-plasma treatment, and postulated as promising alternatives to conventional cancer therapies. Acting as delivery vehicles that allow a controlled release of RONS to the disease...

Descripción completa

Detalles Bibliográficos
Autores: Solé Martí, Xavier|||0000-0002-5544-2485, Vilella, Tània, Labay, Cédric Pierre|||0000-0001-5147-5100, Tampieri, Francesco|||0000-0003-1474-867X, Ginebra Molins, Maria Pau|||0000-0002-4700-5621, Canal Barnils, Cristina|||0000-0002-3039-7462
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Politècnica de Catalunya (UPC)
Repositorio:UPCommons. Portal del coneixement obert de la UPC
Idioma:inglés
OAI Identifier:oai:upcommons.upc.edu:2117/370565
Acceso en línea:https://hdl.handle.net/2117/370565
https://dx.doi.org/10.1039/D2BM00308B
Access Level:acceso abierto
Palabra clave:Biomedical materials
Cancer--Research
Materials biomèdics
Càncer--Investigació
Àrees temàtiques de la UPC::Enginyeria dels materials
Descripción
Sumario:Hydrogels have been recently proposed as suitable materials to generate reactive oxygen and nitrogen species (RONS) upon gas-plasma treatment, and postulated as promising alternatives to conventional cancer therapies. Acting as delivery vehicles that allow a controlled release of RONS to the diseased site, plasma-treated hydrogels can overcome some of the limitations presented by plasma-treated liquids in in vivo therapies. In this work, we optimized the composition of a methylcellulose (MC) hydrogel to confer it with the ability to form a gel at physiological temperatures while remaining in the liquid phase at room temperature to allow gas-plasma treatment with suitable formation of plasma-generated RONS. MC hydrogels demonstrated the capacity for generation, prolonged storage and release of RONS. This release induced cytotoxic effects on the osteosarcoma cancer cell line MG-63, reducing its cell viability in a dose-response manner. These promising results postulate plasma-treated thermosensitive hydrogels as good candidates to provide local anticancer therapies.